Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,166 across all filing types
Latest filing 2025-08-06 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Audio recording of the Earnings Call-Q1 FY26
Regulatory Filings Classification · 95% confidence The document is a short announcement dated August 6, 2025, from Lupin Limited addressed to stock exchanges. It informs about the availability of the audio recording link for the Earnings Call for the quarter ended June 30, 2025 (Q1 FY26). The text does not contain any financial data or detailed transcript but only provides a link to the audio recording. The document length is only 1734 characters, which is quite short and fits the pattern of an announcement rather than the full transcript or report. According to the rules, announcements about earnings calls or their recordings are classified as Call Transcript (CT) only if the full transcript is provided. Since this is only an announcement with a link to the audio recording, it is best classified as a Regulatory Filing (RNS) as a general regulatory announcement. However, given the subject is specifically about the Earnings Call audio recording, and the filing definitions specify Call Transcript (CT) as full text transcripts, this is not a transcript but an announcement of the call recording. Therefore, the best fit is Regulatory Filings (RNS).
2025-08-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement dated August 6, 2025, from Lupin Limited addressed to stock exchanges. It informs about the availability of the audio recording link for the Earnings Call for the quarter ended June 30, 2025 (Q1 FY26). The text does not contain any financial data or detailed transcript but only provides a link to the audio recording. According to the rules, announcements about earnings calls or links to recordings without the full transcript or financial data should be classified as Call Transcript (CT) only if the full transcript is included. Since this is only an announcement of the audio recording availability and not the transcript itself, it is best classified as Regulatory Filings (RNS) as a general regulatory announcement. The document length is short (1734 characters), and it is an announcement rather than the report or transcript itself.
2025-08-06 English
The Company has informed the Exchange about Investor Presentation on the Unaudited Financial Results for the quarter ended on June 30, 2025.
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation Q1 FY26 Results' and is addressed to stock exchanges, indicating it is a formal communication to investors. It contains detailed financial data for the quarter ended June 30, 2025, including sales, EBITDA, net income, segment performance, and key business developments. The content includes forward-looking statements, business strategy, product launches, and market performance metrics. The length is substantial (15,000 characters), and the document is a presentation format rather than a formal report like an annual or interim report. It is not an earnings release (which is typically shorter and less detailed), nor is it a regulatory filing or certification. The document fits the definition of an Investor Presentation (IP) as it focuses on financials, strategy, and market position for the quarter. Therefore, the correct classification is Investor Presentation (IP).
2025-08-06 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is an investor presentation dated August 6, 2025, for Q1 FY26 results of Lupin Limited. It includes detailed financial performance metrics, business highlights, market growth strategies, product launches, regulatory updates, and future outlook. The text explicitly states it is an "Investor Presentation on the Unaudited Financial Results of the Company for the quarter ended on June 30, 2025." The content is consistent with a presentation format aimed at investors, containing charts, key metrics, and strategic commentary rather than a formal regulatory filing or full financial report. The length is substantial (15,000 characters), indicating it is the presentation itself, not just an announcement of a report. Therefore, the appropriate classification is Investor Presentation (IP).
2025-08-06 English
Lupin Q1 FY2026 Results
Interim / Quarterly Report Classification · 100% confidence The document is a press release dated August 5, 2025, announcing the unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). It includes detailed financial highlights such as sales, EBITDA, PBT, PAT, segment sales, and operational highlights. The document references the quarter and fiscal year explicitly and provides comparative figures for the previous quarter and year. It is not a full annual report or audit report but a quarterly financial results announcement. The document is longer than 5,000 characters and contains substantive financial data and analysis, not just a brief announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2025-08-05 English
Press Release
Interim / Quarterly Report Classification · 100% confidence The document is a press release dated August 5, 2025, announcing the unaudited financial results for the quarter ended June 30, 2025 (Q1 FY2026). It contains detailed financial highlights, income statement data, balance sheet highlights, segment sales, operational highlights, and management commentary. The document explicitly states it covers "Unaudited Financial Results of the Company for the quarter ended June 30, 2025." The presence of quarterly financial data and analysis confirms it is a comprehensive interim/quarterly financial report rather than a brief earnings release or a simple announcement. The document length (11,337 characters) and detailed financial tables support this classification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2025-08-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.